SRTD blog image_2

SRTD, Submission Relying on Third-Party Data, Canada, Health Canada, NDS, new drug submission, pharmaceutical regulatory affairs, nonclinical consulting, Canadian drug approval, medical writing services, regulatory affairs Canada, literature-based drug submission